Recently, Chakraborty et al. showed that biallelic loss of TP53/CDKN2A/2B induced BCR-dependent proliferation of CLL cells and transformation into an aggressive RS-like phenotype in vivo and in vitro [18]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.